S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 OragenicsBellerophon TherapeuticsProcessa PharmaceuticalsAssertioDiffusion Pharmaceuticals
SymbolNYSEAMERICAN:OGENNASDAQ:BLPHNASDAQ:PCSANASDAQ:ASRTNASDAQ:DFFN
Price Information
Current Price$1.05$6.63$10.67$0.95$1.03
52 Week RangeHoldBuyBuyBuyHold
MarketRank™
Overall Score0.61.81.21.51.1
Analysis Score0.03.50.03.43.0
Community Score2.63.05.02.52.5
Dividend Score0.00.00.00.00.0
Ownership Score0.01.70.80.80.0
Earnings & Valuation Score0.60.60.00.60.0
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyHold
Consensus Price TargetN/A$26.50N/A$3.50$3.50
% Upside from Price TargetN/A299.70% upsideN/A268.42% upside239.81% upside
Trade Information
Market Cap$81.19 million$62.97 million$112.74 million$107.60 million$70.06 million
Beta0.64-0.29-0.061.681.63
Average Volume34,288,01279,81556,23721,659,69510,889,647
Sales & Book Value
Annual RevenueN/AN/AN/A$229.50 millionN/A
Price / SalesN/AN/AN/A0.47N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.23 per share$0.78 per share$1.46 per share$0.72 per share$0.60 per share
Price / BookN/AN/AN/A1.32N/A
Profitability
Net Income$-15,570,000.00$-13,270,000.00$-3,360,000.00$-217,200,000.00$-11,800,000.00
EPS($0.37)($2.95)N/A($3.07)($1.76)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-145.15%N/A
Return on Equity (ROE)-499.13%-75.84%-79.69%-259.36%-55.70%
Return on Assets (ROA)-178.75%-55.16%-53.85%-55.13%-49.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.01%1.02%N/A
Current Ratio9.55%6.09%0.14%0.80%8.44%
Quick Ratio9.55%6.09%0.14%0.69%8.44%
Ownership Information
Institutional Ownership Percentage12.75%40.22%N/A39.95%8.00%
Insider Ownership Percentage9.90%38.50%54.60%2.69%0.93%
Miscellaneous
Employees7181312510
Shares Outstanding77.32 million9.50 million10.57 million113.26 million68.02 million
Next Earnings Date3/3/2021 (Estimated)4/5/2021 (Estimated)3/5/2021 (Estimated)3/11/2021 (Confirmed)3/16/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.